Facial nerve stimulation in normal pigs and healthy human volunteers: transitional development of a medical device for the emergency treatment of ischemic stroke

Table 3 Adverse events spontaneously reported by the volunteers and reported in response to the query of the study investigator

N = 35	Maximum stimulation power achieved, Tesla (number of volunteers)
N = 35	< 1.0 T (2)	1.0 T (1)	1.2 T (4)	1.4 T (8)	1.6 T (17)	1.8 T (3)
Expected adverse events during stimulation
Metallic taste sensation	0	0	1	1	1	0
Vertigo/sensation of movement	0	0	0	1	2	1
Tinnitus/Ringing ears	0	0	0	0	0	0
Adverse events during stimulation
Visual flashes	0	0	1	2	3	1
Nausea	0	0	0	0	2	1
Sweating	0	0	2	0	7	2
Jaw pain or soreness	0	0	2	5	11	2
Neck pain or soreness	0	0	3	0	1	0
Adverse events after stimulation
Any	0	0	0	0	0	0

Tolerability is shown by the number of volunteers achieving each level of stimulation power

ISSN: 1479-5876